Die Studie

Clinical trial of an existing compound that has been developed for the stimulation of fertility in women.]

  • You are a healthy female.
  • You are at least 18 and no more than 40 years old.
  • You weigh at least 45 kg and your Body Mass Index (BMI) is higher than or equal to 18.0 and lower than or equal to 30.0 kg/m2
  • You did not smoke in the 90 days prior to screening.


  • You cannot participate in the trial if you have participated in another clinical trial in the 60 days prior to the first compound administration in this clinical trial (counting from the last administration of the previous trial).
  • To determine if you are suitable to participate in this trial, you will undergo a medical screening. 

You can only participate if you are not pregnant, not breast feeding, and meet one of the following conditions:

  • You currently use the contraceptive pill. During the trial, you will stop taking your own contraceptive pill, and use the mandatory contraceptive pill (Marvelon) in combination with a condom when having sexual contact with a male partner.


The trial starts with 1 short visit. After that, there will be two periods during which you will stay in the research facility in Groningen for 9 days (8 nights) per period. The follow-up visit will take place on the day of discharge from your last stay at the research facility.

Note: You must be available for all dates to be able to participate in this clinical trial.


  • You will receive a gross compensation of € 6361 for full participation.
  • Travel expenses will be reimbursed based on the distance traveled (€ 0.21 net per kilometer) with a minimum of € 13 and a maximum of € 176.40 (840 kilometers) per round trip, regardless of the mode of transportation.